Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K.

Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578. doi: 10.1038/ajg.2011.425. Epub 2011 Dec 13.

2.

Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.

Lee S, Rhim H, Kim YS, Kang TW, Song KD.

Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18.

PMID:
26503910
3.

Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns.

Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M, Kokubu S, Saigenji K.

J Gastroenterol. 2008;43(1):71-8. doi: 10.1007/s00535-007-2123-z. Epub 2008 Feb 24.

PMID:
18297439
4.

High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.

Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H.

Cancer. 2009 Feb 1;115(3):571-80. doi: 10.1002/cncr.24031.

5.

Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers.

Ueno M, Hayami S, Shigekawa Y, Kawai M, Hirono S, Okada K, Tamai H, Shingaki N, Mori Y, Ichinose M, Yamaue H.

J Hepatol. 2015 Dec;63(6):1352-9. doi: 10.1016/j.jhep.2015.07.013. Epub 2015 Jul 23.

PMID:
26212030
6.

Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.

Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD, Wu JC.

J Clin Gastroenterol. 2012 Jan;46(1):62-70. doi: 10.1097/MCG.0b013e31822b36cc.

PMID:
21934530
7.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276
8.

Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.

Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI.

Cardiovasc Intervent Radiol. 2014 Jun;37(3):705-15. doi: 10.1007/s00270-013-0708-x. Epub 2013 Aug 3.

PMID:
23912493
9.

Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients.

Zhang L, Ge NL, Chen Y, Xie XY, Yin X, Gan YH, Zhang BH, Zhang JB, Chen RX, Wang YH, Ye SL, Ren ZG.

Med Oncol. 2015 Mar;32(3):77. doi: 10.1007/s12032-015-0532-z. Epub 2015 Feb 20.

PMID:
25698535
10.

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M.

Gastroenterology. 2009 Jul;137(1):110-8. doi: 10.1053/j.gastro.2009.04.005. Epub 2009 Apr 9.

11.

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.

Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, Joh JW, Park CK.

Ann Surg Oncol. 2007 Aug;14(8):2319-29. Epub 2007 May 24.

PMID:
17522947
12.

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.

Oncology. 2007;72 Suppl 1:98-103. Epub 2007 Dec 13.

PMID:
18087189
13.

Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.

N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrié N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O.

Hepatology. 2009 Nov;50(5):1475-83. doi: 10.1002/hep.23181.

PMID:
19731239
14.

Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.

Chon YE, Choi GH, Lee MH, Kim SU, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY.

Int J Cancer. 2012 Nov 15;131(10):2332-41. doi: 10.1002/ijc.27507. Epub 2012 Mar 28.

15.

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Wu JC, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD.

Clin Radiol. 2012 May;67(5):429-36. doi: 10.1016/j.crad.2011.10.009. Epub 2011 Dec 6.

PMID:
22153231
16.

Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.

Gao F, Zhu HK, Zhu YB, Shan QN, Ling Q, Wei XY, Xie HY, Zhou L, Xu X, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):371-7.

17.

[Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].

Wu J, Lin S, Wu W, Yan K, Dai Q, Chen M.

Zhonghua Zhong Liu Za Zhi. 2015 Dec;37(12):933-7. Chinese.

PMID:
26887624
18.

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.

Toyoda H, Kumada T, Kaneoka Y, Osaki Y, Kimura T, Arimoto A, Oka H, Yamazaki O, Manabe T, Urano F, Chung H, Kudo M, Matsunaga T.

J Hepatol. 2008 Aug;49(2):223-32. doi: 10.1016/j.jhep.2008.04.013. Epub 2008 May 23.

PMID:
18571271
19.

Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.

Chan SL, Mo F, Johnson P, Li L, Tang N, Loong H, Chan AW, Koh J, Chan AT, Yeo W.

J Gastroenterol Hepatol. 2015 Oct;30(10):1529-35. doi: 10.1111/jgh.13005.

PMID:
25968302
20.

Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.

Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI.

Radiology. 2014 Mar;270(3):900-9. doi: 10.1148/radiol.13130940. Epub 2013 Oct 30.

PMID:
24475823

Supplemental Content

Support Center